Independent firm supports Conformis' pending merger

Orthopedic

ISS, an independent proxy advisory firm, recommended stockholders vote in favor of Conformis' pending merger with Restor3d.

Restor3d is expected to acquire Conformis for $2.27 per share, according to an Aug. 21 news release. The deal was first announced in June.

Under the pending deal, Restor3d will acquire all of the outstanding stock shares of Conformis in cash. Conformis' board of directors unanimously approved the transaction.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers